Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis

被引:53
作者
Lamba, Nayan [1 ,2 ]
Muskens, Ivo S. [1 ,3 ]
DiRisio, Aislyn C. [1 ]
Meijer, Louise [3 ]
Briceno, Vanessa [4 ]
Edrees, Heba [4 ]
Aslam, Bilal [4 ]
Minhas, Sadia [4 ]
Verhoeff, Joost J. C. [5 ]
Kleynen, Catharina E. [5 ]
Smith, Timothy R. [1 ]
Mekary, Rania A. [1 ,4 ]
Broekman, Marike L. [1 ,3 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, CNOC, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurosurg, HP G03-124,Box 855003508 GA, Utrecht, Netherlands
[4] MCPHS Univ, Sch Pharm, Boston, MA USA
[5] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands
关键词
Brain Metastasis; Resection; Whole brain radiation; Stereotactic radiosurgery; Meta-analysis; SURGICAL RESECTION; RADIATION-THERAPY; MULTIDISCIPLINARY TREATMENT; POSTOPERATIVE RADIOTHERAPY; PROGNOSTIC-FACTORS; SINGLE; CANCER; CAVITY; SURVIVAL; BOOST;
D O I
10.1186/s13014-017-0840-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In patients with one to three brain metastases who undergo resection, options for post-operative treatments include whole-brain radiotherapy (WBRT) or stereotactic radiosurgery (SRS) of the resection cavity. In this meta-analysis, we sought to compare the efficacy of each post-operative radiation modality with respect to tumor recurrence and survival. Methods: Pubmed, Embase and Cochrane databases were searched through June 2016 for cohort studies reporting outcomes of SRS or WBRT after metastasis resection. Pooled effect estimates were calculated using fixed-effect and random-effect models for local recurrence, distant recurrence, and overall survival. Results: Eight retrospective cohort studies with 646 patients (238 with SRS versus 408 with WBRT) were included in the analysis. Comparing SRS to WBRT, the overall crude risk ratio using the fixed-effect model was 0.59 for local recurrence (95%-CI: 0.32-1.09, I-2: 3.35%, P-heterogeneity = 0.36, 3 studies), 1.09 for distant recurrence (95%-CI: 0.74-1.60, I-2: 50.5%, P-heterogeneity = 0.13; 3 studies), and 2.99 for leptomeningeal disease (95% CI1. 55-5.76; I-2: 14.4% p-heterogeneity: 0. 28; 2 studies). For the same comparison, the risk ratio for median overall survival was 0.47 (95% CI: 0.41-0.54; I-2: 79.1%, P-heterogeneity < 0.01; 4 studies) in a fixed-effect model, but was no longer significant (0.63; 95%-CI: 0.40-1.00) in a random-effect model. SRS was associated with a lower risk of leukoencephalopathy (RR: 0.15, 95% CI: 0.07-0.33, 1 study), yet with a higher risk of radiation-necrosis (RR: 19.4, 95% CI: 1.21-310, 1 study). Conclusion: Based on retrospective cohort studies, the results of this study suggest that SRS of the resection cavity may offer comparable survival and similar local and distant control as adjuvant WBRT, yet may be associated with a higher risk for developing leptomeningeal disease. Future research on SRS should focus on achieving a better understanding of the various factors that may favor SRS over WBRT.
引用
收藏
页数:12
相关论文
共 40 条
[1]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[2]  
[Anonymous], ISRN SURG
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases [J].
Atalar, Banu ;
Modlin, Leslie A. ;
Choi, Clara Y. H. ;
Adler, John R. ;
Gibbs, Iris C. ;
Chang, Steven D. ;
Harsh, Griffith R. ;
Li, Gordon ;
Nagpal, Seema ;
Hanlon, Alexandra ;
Soltys, Scott G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (04) :713-718
[5]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[6]   Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system [J].
Barnholtz-Sloan, JS ;
Sloan, AE ;
Davis, FG ;
Vigneau, FD ;
Lai, P ;
Sawaya, RE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2865-2872
[7]   A Phase 2 Trial of Stereotactic Radiosurgery Boost After Surgical Resection for Brain Metastases [J].
Brennan, Cameron ;
Yang, T. Jonathan ;
Hilden, Patrick ;
Zhang, Zhigang ;
Chan, Kelvin ;
Yamada, Yoshiya ;
Chan, Timothy A. ;
Lymberis, Stella C. ;
Narayana, Ashwatha ;
Tabar, Viviane ;
Gutin, Philip H. ;
Ballangrud, Ase ;
Lis, Eric ;
Beal, Kathryn .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (01) :130-136
[8]   Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].
Chang, Eric L. ;
Wefel, Jeffrey S. ;
Hess, Kenneth R. ;
Allen, Pamela K. ;
Lang, Frederick F. ;
Kornguth, David G. ;
Arbuckle, Rebecca B. ;
Swint, J. Michael ;
Shiu, Almon S. ;
Maor, Moshe H. ;
Meyers, Christina A. .
LANCET ONCOLOGY, 2009, 10 (11) :1037-1044
[9]   Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases: Prospective Evaluation of Target Margin on Tumor Control [J].
Choi, Clara Y. H. ;
Chang, Steven D. ;
Gibbs, Iris C. ;
Adler, John R. ;
Harsh, Griffith R. ;
Lieberson, Robert E. ;
Soltys, Scott G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (02) :336-342
[10]   THE ROLE OF POSTOPERATIVE RADIOTHERAPY AFTER RESECTION OF SINGLE BRAIN METASTASES [J].
DEANGELIS, LM ;
MANDELL, LR ;
THALER, HT ;
KIMMEL, DW ;
GALICICH, JH ;
FUKS, Z ;
POSNER, JB .
NEUROSURGERY, 1989, 24 (06) :798-805